Molecular medicine of microRNAs: Structure, function and implications for diabetes

Expert Reviews in Molecular Medicine

Volumn 10, Issue 24, 2008, Pages 1-20

  Hennessy, Erica ^a   O'Driscoll, Lorraine ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ARGONAUTE 2 PROTEIN; BETA INTERFERON; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; GEMININ; HEPATOCYTE NUCLEAR FACTOR 3BETA; INITIATION FACTOR 4E; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; LIM KINASE 1; MICRORNA; MICRORNA 124A; MICRORNA 133; MICRORNA 192; MICRORNA 375; MICRORNA 9; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN VIIA; POTASSIUM CHANNEL HERG; RAB27A PROTEIN; RECOMBINANT SOMATOMEDIN C; RNA; SULFONYLUREA RECEPTOR 1; SYNAPTOBREVIN 2; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN 1; TRANSCRIPTION FACTOR PDX 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTISENSE THERAPY; ARTICLE; BIOGENESIS; BURKITT LYMPHOMA; CARDIOVASCULAR DISEASE; CHRONIC LYMPHATIC LEUKEMIA; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DRUG MECHANISM; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC REGULATION; GENETIC STABILITY; GENETIC VARIABILITY; HUMAN; INSULIN RELEASE; MOLECULAR EVOLUTION; MOLECULAR MECHANICS; NEUROLOGIC DISEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA STRUCTURE; RNA TRANSLATION; VIRUS INFECTION;

MAMMALIA;

EID: 50249172898     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399408000781     Document Type: Article

References (180)

1. Bartel, D.P. and Chen, C.Z. (2004) Micromanagers of gene expression: The potentially widespread influence of metazoan microRNAs. Nat Rev Genet 5, 396-400
2. Zamore, P.D. (2004) Plant RNAi: How a viral silencing suppressor inactivates siRNA. Curr Biol 14, R198-200
3. Kumar, A. (2008) RNA interference: A multifaceted innate antiviral defense. Retrovirology 5, 17
4. Lau, N.C. et al. (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans, Science 294, 858-862
5. He, L. et al. (2005) A n-dcroRNA polycistron as a potential human oncogene. Nature 435, 828-833
6. Bartel, D.P. (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297
7. Brennecke, J. et al. (2005) Principles of microRNA-target recognition. PLoS Biol 3, e85
8. Leung, A.K. and Sharp, P.A. (2007) microRNAs: A safeguard against turmoil? Cell 130, 581-585
9. Lim, L.P. et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773
10. Lim, L.P. et al. (2003) Vertebrate microRNA genes. Science 299, 1540
11. Zamore, P.D. and Haley, B. (2005) Ribo-gnome: The big world of small RNAs- Science 309, 1519-1524
12. Rajewsky, N. (2006) microRNA target predictions in animals. Nat Genet 38 Suppl, S8-13
13. Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to hn-14. Cell 75, 843-854
14. Ha, L., Wightman, B. and Ruvkun, G. (1996) A bulged lin-4/lin-14 RNA duplex is sufficient for Caenorhabditis elegans lin-14 temporal gradient formation. Genes Dev 10, 3041-3050
15. Olsen, P.H. and Ambros, V (1999) The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol 216, 671-680
16. Reinhart, B.J. et al. (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901-906
17. Slack, E.J. et al. (2000) The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LN-29 transcription factor. Mol Cell 5, 659-669
18. Lin, S.Y. et al. (2003) The C elegans hunchback homolog, hbl-1, controls temporal patterning and is a probable microRNA target. Dev Cell 4, 639-650
19. Vella, M.C. et al. (2004) The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3′UTR. Genes Dev 18, 132-137
20. Takuno, S. and Innan, H. (2008) Evolution of complexity in miRNA-mediated gene regulation systems. Trends Genet 24, 56-59
21. Blow, M.J. et al. (2006) RNA editing of human microRNAs. Genome Biol 7, R27
22. Lee, Y. et al. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23, 4051-4060
23. Borchert, G.M., Lanier, W. and Davidson, B.L. (2006) RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 13, 1097-1101
24. Cai, X., Hagedorn, C.H. and Cullen, B.R. (2004) Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10, 1957-1966
25. Denli, A.M. et al. (2004) Processing of primary microRNAs by the Microprocessor complex. Nature 432, 231-235
26. Gregory, R.I. et al. (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature 432, 235-240
27. Han, J. et al. (2004) The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18, 3016-3027
28. Lee, Y. et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419
29. Ruby, J.G., Jan, C.H. and Bartel, D.P. (2007) Intronic microRNA precursors that bypass Drosha processing. Nature 448, 83-86
30. Jiang, F. et al. (2005) Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila. Genes Dev 19, 1674-1679
31. Chendrimada, T.P. et al. (2005) TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436, 740-744
32. Saito, K. et al. (2005) Processing of pre-microRNAs by the Dicer-1-Loquacious complex in Drosophila cells. PLoS Biol 3, e235
33. Gregory, R.I. et al. (2005) Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123, 631-640
34. Maniataki, E. and Mourelatos, Z. (2005) A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes Dev 19, 2979-2990
35. Nykanen, A., Haley, B. and Zamore, P.D. (2001) ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107, 309-321
36. Cook, H.A. et al. (2004) The Drosophila SDE3 homolog armitage is required for oskar mRNA silencing and embryonic axis specification. Cell 116, 817-829
37. Mourelatos, Z. et al. (2002) miRNPs: A novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev 16, 720-728
38. Pillai, R.S., Artus, C.G. and Filipowicz, W. (2004) Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis. RNA 10, 1518-1525
39. Caudy, A.A. et al. (2002) Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev 16, 2491-2496
40. Caudy, A.A. et al. (2003) A micrococcal nuclease homologue in RNAi effector complexes. Nature 425, 411-414
41. Hwang, H.W., Wentzel, E.A. and Mendell, J.T. (2007) A hexanucleotide element directs microRNA nuclear import. Science 315, 97-100
42. Zeng, Y., Yi, R. and Cullen, B.R. (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A 100, 9779-9784
43. Bagga, S. et al. (2005) Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122, 553-563
44. Jing, Q. et al. (2005) Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120, 623-634
45. Giraldez, A.J. et al. (2006) Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science 312, 75-79
46. Humphreys, D.T. et al. (2005) MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci U S A 102, 16961-16966
47. Wang, B. et al. (2006) Recapitulation of short RNA-directed translational gene silencing in vitro. Mol Cell 22, 553-560
48. Mathonnet, G. et al. (2007) MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317, 1764-1767
49. Wakiyama, M. et al. (2007) Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system. Genes Dev 21, 1857-1862
50. Pillai, R.S. et al. (2005) Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309, 1573-1576
51. Kiriakidou, M. et al. (2007) An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell 129, 1141-1151
52. Chendrimada, T.P. et al. (2007) MicroRNA silencing through RISC recruitment of eIF6. Nature 447, 823-828
53. Petersen, C.P. et al. (2006) Short RNAs repress translation after initiation in mammalian cells. Mol Cell 21, 533-542
54. Seggerson, K., Tang, L. and Moss, E.G. (2002) Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev Biol 243, 215-225
55. Behm-Ansmant, I. et al. (2006) mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev 20, 1885-1898
56. Sen, G.L. and Blau, H.M. (2005) Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat Cell Biol 7, 633-636
57. Liu, J. et al. (2005) MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7, 719-723
58. Jakymiw, A. et al. (2005) Disruption of GW bodies impairs mammalian RNA interference. Nat Cell Biol 7, 1267-1274
59. Meister, G. et al. (2005) Identification of novel argonaute-associated proteins. Curr Biol 15, 2149-2155
60. Parker, R. and Song, H. (2004) The enzymes and control of eukaryotic mRNA turnover. Nat Struct Mol Biol 11, 121-127
61. Pillai, R.S., Bhattacharyya, S.N. and Filipowicz, W. (2007) Repression of protein synthesis by miRNAs: How many mechanisms? Trends Cell Biol 17, 118-126
62. Schmitter, D. et al. (2006) Effects of Dicer and Argonaute down-regulation on mRNA levels in human HEK293 cells. Nucleic Acids Res 34, 4801-4815
63. Rehwinkel, J. et al. (2005) A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 11, 1640-1647
64. Brengues, M., Teixeira, D. and Parker, R. (2005) Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science 310, 486-489
65. Vasudevan, S. and Steitz, J.A. (2007) AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 128, 1105-1118
66. Vasudevan, S., Tong, Y. and Steitz, J.A. (2007) Switching from repression to activation: MicroRNAs can up-regulate translation. Science 318, 1931-1934
67. Vasudevan, S., Tong, Y. and Steitz, J.A. (2008) Cell-cycle control of microRNA-mediated translation regulation. Cell Cycle 7, 1545-1549
68. Jopling, C.L. et al. (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309, 1577-1581
69. Yoon, S. and De Micheli, G. (2006) Computational identification of microRNAs and their targets. Birth Defects Res C Embryo Today 78, 118-128
70. Bentwich, I. et al. (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37, 766-770
71. Kiriakidou, M. et al. (2004) A combined computational-experimental approach predicts human microRNA targets. Genes Dev 18, 1165-1178
72. Lewis, B.P. et al. (2003) Prediction of mammalian microRNA targets. Cell 115, 787-798
73. Farh, K.K. et al. (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310, 1817-1821
74. Bentwich, I. (2005) Prediction and validation of microRNAs and their targets. FEBS Lett 579, 5904-5910
75. Stark, A. et al. (2005) Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3′UTR evolution. Cell 123, 1133-1146
76. Sood, P, et al. (2006) Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci U S A 103, 2746-2751
77. Maziere, P. and Enright, A.J. (2007) Prediction of microRNA targets. Drug Discov Today 12, 452-458
78. Zilberstein, C.B. et al. (2006) A high-throughput approach for associating MicroRNAs with their activity conditions. J Comput Biol 13, 245-266
79. Berezikov, E., Cuppen, E. and Plasterk, R.H. (2006) Approaches to microRNA discovery. Nat Genet 38 Suppl, S2-7
80. Krichevsky, A.M. et al. (2003) A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9, 1274-1281
81. Babak, T. et al. (2004) Probing microRNAs with microarrays: Tissue specificity and functional inference. RNA 10, 1813-1819
82. Barad, O. et al. (2004) MicroRNA expression detected by oligonucleotide microarrays: System establishment and expression profiling in human tissues. Genome Res 14, 2486-2494
83. Liu, C.G. et al. (2004) An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A 101, 9740-9744
84. Miska, E.A. et al. (2004) Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol 5, R68
85. Sun, Y. et al. (2004) Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res 32, e188
86. Thomson, J.M. et al. (2004) A custom microarray platform for analysis of microRNA gene expression. Nat Methods 1, 47-53
87. Baskerville, S. and Bartel, D.P. (2005) Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11, 241-247
88. Monticelli, S. et al. (2005) MicroRNA profiling of the murine hematopoietic system. Genome Biol 6, R71
89. Shingara, J. et al. (2005) An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 11, 1461-1470
90. Wienholds, E. et al. (2005) MicroRNA expression in zebrafish embryonic development. Science 309, 310-311
91. Castoldi, M. et al. (2006) A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA 12, 913-920
92. Nelson, P.T. et al. (2004) Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Methods 1, 155-161
93. Lu, J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435, 834-838
94. Allawi, H.T. et al. (2004) Quantitation of MicroRNAs using a modified Invader assay. RNA 10, 1153-1161
95. Kim, VN. and Nam, JW (2006) Genomics of microRNA. Trends Genet 22, 165-173
96. Krutzfeldt, J. et al. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689
97. Davis, S. et al. (2006) Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res 34, 2294-2304
98. Esau, C. et al. (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3, 87-98
99. Zhou, H., Huang, C. and Xia, X.G. (2008) A tightly regulated Po1 III promoter for synthesis of miRNA genes in tandem. Biochim Biophys Acta, Apr 7
100. Esau, C. et al. (2004) MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279, 52361-52365
101. Brennecke, J. et al. (2003) bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113, 25-36
102. Krutzfeldt, J. and Stoffel, M. (2006) MicroRNAs: A new class of regulatory genes affecting metabolism. Cell Metab 4, 9-12
103. Chen, C.Z. et al. (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83-86
104. Zhao, Y., Samal, E. and Srivastava, D. (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436, 214-220
105. Poy, M.N. et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432, 226-230
106. Carthew, R.W (2006) Gene regulation by microRNAs. Curr Opin Genet Dev 16, 203-208
107. Harfe, B.D. et al. (2005) The RNaseIlI enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci U S A 102, 10898-10903
108. Dostie, J. et al. (2003) Numerous microRNPs in neuronal cells containing novel microRNAs. RNA 9, 180-186
109. Jin, P. et al. (2004) Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci 7, 113-117
110. Abelson, J.E et al. (2005) Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310, 317-320
111. Schratt, G.M. et al. (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439, 283-289
112. Calin, G.A. et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101, 2999-3004
113. Calin, G.A. et al. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99, 15524-15529
114. Stilgenbauer, S. et al. (1998) Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 16, 1891-1897
115. Johnson, S.M. et al. (2005) RAS is regulated by the let-7 microRNA family. Cell 120, 635-647
116. Costinean, S. et al. (2006) Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A 103, 7024-7029
117. Lecellier, C.H. et al. (2005) A cellular microRNA mediates antiviral defense in human cells. Science 308, 557-560
118. Bennasser, Y. et al. (2005) Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22, 607-619
119. Sullivan, C.S. and Ganem, D. (2005) A virus-encoded inhibitor that blocks RNA interference in mammalian cells. J Virol 79, 7371-7379
120. Samols, M.A. et al. (2007) Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 3, e65
121. Sullivan,C.S. et al. (2005)SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic Tcells. Nature 435,682-686
122. Cullen, B.R. (2006) Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat Immunol. 7, 563-567
123. Pedersen, I.M. et al. (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449, 919-922
124. Nathan, D.M. (1993) Long-term complications of diabetes mellitus. N Engl J Med 328, 1676-1685
125. [No authors listed] (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329, 977-986
126. O'Driscoll, L., Gammell, P. and Clynes, M. (2004) Mechanisms associated with loss of glucose responsiveness in beta cells. Transplant Proc 36, 1159-1162
127. O'Driscoll, L. et al. (2006) Phenotypic and global gene expression profile changes between low passage and high passage MIN-6 cells. J Endocrinol 191, 665-676
128. Dowling, P. et al. (2006) Proteomic screening of glucose-responsive and glucose non-responsive MIN-6 beta cells reveals differential expression of proteins involved in protein folding, secretion and oxidative stress. Proteomics 6, 6578-6587
129. Abderrahmani, A. et al. (2006) Mechanisms controlling the expression of the components of the exocytotic apparatus under physiological and pathological conditions. Biochem Soc Trans 34, 696-700
130. Dunn, W. et al. (2005) Human cytomegalovirus expresses novel microRNAs during productive viral infection. Cell Microbiol 7, 1684-1695
131. Yamakuni, T. et al. (2002) V-1, a catecholamine biosynthesis regulatory protein, positively controls catecholamine secretion in PC12D cells. FEBS Lett 530, 94-98
132. Antonin, W., Riedel, D. and von Mollard, G.F. (2000) The SNARE Vtila-beta is localized to small synaptic vesicles and participates in a novel SNARE complex. J Neurosci 20, 5724-5732
133. Taoka, M. et al. (2003) V-1, a protein expressed transiently during murine cerebellar development, regulates actin polymerization via interaction with capping protein. J Biol Chem 278, 5864-5870
134. Hammar, E.B. et al. (2005) Activation of NF-kappaB by extracellular matrix is involved in spreading and glucose-stimulated insulin secretion of pancreatic beta cells. J Biol Chem 280, 30630-30637
135. Norlin, S., Ahlgren, U. and Edlund, H. (2005) Nuclear factor-{kappa}B activity in {beta}-cells is required for glucose-stimulated insulin secretion. Diabetes 54, 125-132
136. Krek, A. et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37, 495-500
137. Kloosterman, W.P. et al. (2007) Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol 5, e203
138. Baroukh, N. et al. (2007) MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem 282, 19575-19588
139. Enright, A.J. et al. (2003) MicroRNA targets in Drosophila. Genome Biol 5, R1
140. Zhang, X. et al. (2005) Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A 102, 4459-4464
141. Wu, K.L. et al. (1997) Hepatocyte nuclear factor 3beta is involved in pancreatic beta-cell-specific transcription of the pdx-1 gene. Mol Cell Biol 17, 6002-6013
142. Lee, C.S. et al. (2002) Foxa2 controls Pdx1 gene expression in pancreatic beta-cells in vivo. Diabetes 51, 2546-2551
143. Jonsson, J. et al. (1994) Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371, 606-609
144. Offield, M.F. et al. (1996) PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122, 983-995
145. Stoffers, D.A. et al. (1997) Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 15, 106-110
146. Lantz, K.A. et al. (2004) Foxa2 regulates multiple pathways of insulin secretion. J Clin Invest 114, 512-520
147. Meissner, T., Beinbrech, B. and Mayatepek, E. (1999) Congenital hyperinsulinism: Molecular basis of a heterogeneous disease. Hum Mutat 13, 351-361
148. Kasai, K. et al. (2005) Rab27a mediates the tight docking of insulin granules onto the plasma membrane during glucose stimulation. J Clin Invest 115, 388-396
149. Lovis, P., Gattesco, S. and Regazzi, R. (2008) Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem 389, 305-312
150. Lagos-Quintana, M. et al. (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12, 735-739
151. Landgraf, P. et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414
152. Plaisance, V. et al. (2006) MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 281, 26932-26942
153. Wang, J. et al. (1999) Novel rabphilin-3-like protein associates with insulin-containing granules in pancreatic beta cells. J Biol Chem 274, 28542-28548
154. Torii, S. et al. (2004) Rab27 effector granuphilin promotes the plasma membrane targeting of insulin granules via interaction with syntaxin 1a. J Biol Chem 279, 22532-22538
155. Gomi, H. et al. (2005) Granuphilin molecularly docks insulin granules to the fusion machinery. J Cell Biol 171, 99-109
156. Coppola, T. et al. (2002) Pancreatic beta-cell protein granuphilin binds Rab3 and Munc-18 and controls exocytosis. Mol Biol Cell 13, 1906-1915
157. Torii, S. et al. (2002) Granuphilin modulates the exocytosis of secretory granules through interaction with syntaxin 1a. Mol Cell Biol 22, 5518-5526
158. Schleicher, E.D. and Olgemoller, B. (1992) Glomerular changes in diabetes mellitus. Eur J Clin Chem Clin Biochem 30, 635-640
159. Ziyadeh, F.N. (1993) The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22, 736-744
160. Reeves, W.B. and Andreoli, T.E. (2000) Transforming growth factor beta contributes to progressive diabetic nephropathy. Proc Natl Acad Sci U S A 97, 7667-7669
161. Sharma, K. and Ziyadeh, F.N. (1995) Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44, 1139-1146
162. Poncelet, A.C. and Schnaper, H.W. (2001) Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem 276, 6983-6992
163. Tsuchida, K. et al. (2003) Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells. Kidney Int 63, 2000-2009
164. Chin, B.Y. et al. (2001) Stimulation of proalpha(1)(I) collagen by TGF-beta(1) in mesangial cells: Role of the p38 MAPK pathway. Am J Physiol Renal Physiol 280, F495-504
165. Hayashida, T. et al. (1999) TGF-beta1 activates MAP kinase in human mesangial cells: A possible role in collagen expression. Kidney Int 56, 1710-1720
166. Kato, M. et al. (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 104, 3432-3437
167. Postigo, A.A. (2003) Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. EMBO J 22, 2443-2452
168. Liu, S. et al. (2005) ERK-dependent signaling pathway and transcriptional factor Ets-1 regulate matrix metalloproteinase-9 production in transforming growth factor-beta1 stimulated glomerular podocytes. Cell Physiol Biochem 16, 207-216
169. Donnelly, R. et al. (2000) ABC of arterial and venous disease: Vascular complications of diabetes. BMJ 320, 1062-1066
170. Duncan, C. et al. (1992) An audit of non-insulin-dependent diabetics attending a district general hospital diabetic clinic: Implications for shared care between hospital and general practice. Health Bull (Edinb) 50, 302-308
171. Casis, O. and Echevarria, E. (2004) Diabetic cardiomyopathy: electromechanical cellular alterations. Curr Vasc Pharmacol 2, 237-248
172. Veglio, M., Chinaglia, A. and Cavallo-Perin, P. (2004) QT interval, cardiovascular risk factors and risk of death in diabetes. J Endocrinol Invest 27, 175-181
173. Zhang, Y. et al. (2007) Ionic mechanisms underlying abnormal QT prolongation and the associated arrhythmias in diabetic rabbits: A role of rapid delayed rectifier K+ current. Cell Physiol Biochem 19, 225-238
174. Zhang, Y. et al. (2006) Restoring depressed HERG K+ channel function as a mechanism for insulin treatment of abnormal QT prolongation and associated arrhythmias in diabetic rabbits. Am J Physiol Heart Circ Physiol 291, H1446-1455
175. Xiao, J. et al. (2007) MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 282, 12363-12367
176. Chen, J.F. et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38, 228-233
177. Luo, X. et al. (2007) Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of IKs-encoding genes and potential implications in regional heterogeneity of their expressions. J Cell Physiol 212, 358-367
178. Esau, C.C. and Monia, B.P. (2007) Therapeutic potential for microRNAs. Adv Drug Deliv Rev 59, 101-114
179. He, A. et al. (2007) Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 21, 2785-2794
180. Lynn, F.C. et al. (2007) MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 56, 2983-2945